EU approves Roche drug Columvi for lymphoma treatment
Roche: EU approves Columvi for lymphoma treatment
Keystone-SDA
Select your language
Generated with artificial intelligence.
Listening: EU approves Roche drug Columvi for lymphoma treatment
The European Commission has approved Roche's Columvi as the first bispecific antibody for the treatment of diffuse large B-cell lymphoma after initial therapy, the pharmaceutical giant announced on Monday.
This content was published on
2 minutes
Keystone-SDA
Italiano
it
Roche: Ue approva Columvi per trattamento linfoma
Original
The approval is based on the result of the phase III Starglo trial, during which Columvi – combined with Gemcitabine and oxaliplatin (GemOx) – demonstrated a “statistically and clinically significant improvement in survival” compared to other treatments, Roche explained.
Relapsed or refractory diffuse large B-cell lymphoma (DLBCL) is an aggressive cancer with a high risk of progression, which means that urgent and effective treatments are needed. In primary analyses, a 41% reduction in the risk of death was found among patients treated with Columvi and GemOx.
Translated from Italian by DeepL/ts
How we work
We select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate them into English. An editor then briefly reviews the translation for clarity and accuracy before publication. Providing you with automatically translated news gives us the time to write more in-depth articles. The news stories we select have been written and carefully fact-checked by an external editorial team from news agencies such as Bloomberg or Keystone.
Train vs plane: would you take a direct train between London and Geneva?
Eurostar is planning to run direct trains from Britain to Germany and Switzerland from the early 2030s. Would you favour the train over the plane? If not, why not?
New Swiss 3D simulation tool offers better landslide forecasting
This content was published on
A new 3D simulation tool is enabling much more accurate avalanche forecasts. The model, which proved its worth during the landslides in Brienz (GR) and Blatten (VS), could lead to more effective management of alpine risks.
Alleged leader of Kosovar terrorist group indicted in Switzerland
This content was published on
The Office of the Attorney General of Switzerland has brought charges against a Kosovar on suspicion of being the leader of the Swiss branch of a Kosovar terrorist organisation. He is also suspected of having been active in the management of the organisation in Kosovo.
Swiss glacier lake drains without causing flooding damage
This content was published on
The Faverges glacial lake on the Plaine Morte above Lenk in the Bernese Oberland drained over the weekend. There was no flooding or damage, the authorities announced on Monday.
Chihuahua leads Swiss rescue team to owner stuck in a crevasse
This content was published on
A Chihuahua helped to rescue a man on the Fee Glacier above Saas-Fee VS on Friday. It alerted a rescue team to its owner who had fallen into a crevasse.
Swiss bosses distance themselves from the United States
This content was published on
According to a survey of managers, Swiss companies are increasingly turning away from the USA and orientating themselves more towards Southeast Asia and the EU. This is the result of a recent survey.
This content was published on
The Fête de l'Epouvantail (scarecrow festival) is celebrating its 30th anniversary and returns to Denens in canton Vaud for its seventh edition from July 10-20.
This content was published on
A 35-year-old man has died in a work accident at the valley station of the Heimwehfluh toboggan run in Matten near Interlaken, canton Bern.
This content was published on
The Swiss embassy in Tehran re-opened on Sunday after being closed on June 20 owing to the unstable situation in the country.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.